Crossmark

New insights into the mechanisms of anandamide-induced airway dilation placing its degradation enzyme, FAAH center stage. Commentary on: Simon A, von Einem T, Seidinger A, Matthey M, Bindila L, Wenzel D (2022) The endocannabinoid anandamide is an airway relaxant in health and disease. Nat Commun 13:6941

Crossref DOI link: https://doi.org/10.1007/s00424-023-02802-2

Published Online: 2023-03-01

Published Print: 2023-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Pfitzer, Gabriele
Funding

Funding for this research was provided by:

Universitätsklinikum Köln
License Information

Text and Data Mining valid from 2023-03-01

Version of Record valid from 2023-03-01
More Information

Article History

Received: 20 February 2023

Revised: 20 February 2023

Accepted: 22 February 2023

First Online: 1 March 2023

Declarations

:

: Not applicable.

: Not applicable.

: The author gives her consent with the publication of the commentar.

: The author declares no competing interests.

Document is current

Any future updates will be listed below